$PCOR
PROCORE TECHNOLOGIES, INC.

2022 Q4 Form 10-Q Financial Statement

#000156459022036765 Filed on November 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $202.1M $186.4M $146.1M
YoY Change 38.29% 41.24%
Cost Of Revenue $40.57M $37.78M $29.77M
YoY Change 36.29% 66.48%
Gross Profit $161.5M $148.7M $116.3M
YoY Change 38.81% 36.01%
Gross Profit Margin 79.92% 79.74% 79.63%
Selling, General & Admin $157.5M $149.0M $127.9M
YoY Change 23.18% 41.87%
% of Gross Profit 97.54% 100.22% 109.91%
Research & Development $72.88M $71.49M $59.77M
YoY Change 21.94% 36.07%
% of Gross Profit 45.13% 48.09% 51.37%
Depreciation & Amortization $16.59M $15.90M $13.11M
YoY Change 26.54% 95.15% -34.47%
% of Gross Profit 10.27% 10.7% 11.27%
Operating Expenses $234.3M $220.5M $190.8M
YoY Change 22.83% 38.78%
Operating Profit -$72.86M -$71.81M -$74.45M
YoY Change -2.13% 44.91%
Interest Expense $4.467M $504.0K -$494.0K
YoY Change -1004.25% -196.74%
% of Operating Profit
Other Income/Expense, Net -$692.0K -$698.0K $37.00K
YoY Change -1970.27% 6.89%
Pretax Income -$71.43M -$70.87M -$74.91M
YoY Change -4.65% 39.7%
Income Tax -$243.0K $300.0K -$23.94M
% Of Pretax Income
Net Earnings -$71.18M -$71.21M -$50.97M
YoY Change 39.65% 40.33%
Net Earnings / Revenue -35.23% -38.19% -34.89%
Basic Earnings Per Share -$0.52
Diluted Earnings Per Share -$0.51 -$0.52 -$550.0K
COMMON SHARES
Basic Shares Outstanding 138.0M 136.8M
Diluted Shares Outstanding 137.2M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $582.2M $558.1M $586.1M
YoY Change -0.67% -47.95%
Cash & Equivalents $296.7M $264.6M $586.1M
Short-Term Investments $285.5M $293.4M $0.00
Other Short-Term Assets $44.73M $49.91M $35.17M
YoY Change 27.17% 109.0%
Inventory
Prepaid Expenses
Receivables $148.7M $106.7M $114.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $799.2M $735.4M $752.3M
YoY Change 6.24% -38.02% 54.17%
LONG-TERM ASSETS
Property, Plant & Equipment $39.19M $40.67M $36.84M
YoY Change 6.4% -65.42% 21.77%
Goodwill $539.1M $539.0M $540.9M
YoY Change -0.33% 292.36% 329.42%
Intangibles $163.0M
YoY Change
Long-Term Investments
YoY Change
Other Assets $21.90M $22.09M $22.01M
YoY Change -0.47% 82.1% 112.03%
Total Long-Term Assets $941.2M $941.9M $938.4M
YoY Change 0.3% 165.62% 181.96%
TOTAL ASSETS
Total Short-Term Assets $799.2M $735.4M $752.3M
Total Long-Term Assets $941.2M $941.9M $938.4M
Total Assets $1.740B $1.677B $1.691B
YoY Change 2.94% 8.84% 105.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.28M $16.28M $15.49M
YoY Change -7.8% 82.62% 71.88%
Accrued Expenses $99.18M $83.08M $65.91M
YoY Change 50.49% 48.19% 131.32%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $531.6M $458.9M $403.7M
YoY Change 31.69% 44.54% 54.26%
LONG-TERM LIABILITIES
Long-Term Debt $45.58M $45.79M $47.34M
YoY Change -3.73% -4.01%
Other Long-Term Liabilities $3.049M $3.352M $4.723M
YoY Change -35.44% -93.82% 146.12%
Total Long-Term Liabilities $3.049M $3.352M $4.723M
YoY Change -35.44% -96.71% 146.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $531.6M $458.9M $403.7M
Total Long-Term Liabilities $3.049M $3.352M $4.723M
Total Liabilities $623.6M $553.0M $501.4M
YoY Change 24.39% 31.83% 37.21%
SHAREHOLDERS EQUITY
Retained Earnings -$949.1M -$878.0M -$662.2M
YoY Change 43.33% 66.78%
Common Stock $14.00K $14.00K $13.00K
YoY Change 7.69% 333.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.117B $1.124B $1.189B
YoY Change
Total Liabilities & Shareholders Equity $1.740B $1.677B $1.691B
YoY Change 2.94% 8.84% 105.99%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$71.18M -$71.21M -$50.97M
YoY Change 39.65% 40.33%
Depreciation, Depletion And Amortization $16.59M $15.90M $13.11M
YoY Change 26.54% 95.15% -34.47%
Cash From Operating Activities $22.69M $6.587M -$3.575M
YoY Change -734.74% -56.49% -120.77%
INVESTING ACTIVITIES
Capital Expenditures $10.98M -$12.77M -$9.051M
YoY Change -221.28% 47.27% -22.9%
Acquisitions
YoY Change
Other Investing Activities $9.147M -$295.5M -$490.7M
YoY Change -101.86% 3693250.0% 4273.41%
Cash From Investing Activities -$1.830M -$308.2M -$499.7M
YoY Change -99.63% 3451.92% 2076.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.394M 4.255M 16.88M
YoY Change -44.35% -21.71% -83.67%
NET CHANGE
Cash From Operating Activities 22.69M 6.587M -3.575M
Cash From Investing Activities -1.830M -308.2M -499.7M
Cash From Financing Activities 9.394M 4.255M 16.88M
Net Change In Cash 30.26M -297.4M -486.4M
YoY Change -106.22% -2600.16% -598.46%
FREE CASH FLOW
Cash From Operating Activities $22.69M $6.587M -$3.575M
Capital Expenditures $10.98M -$12.77M -$9.051M
Free Cash Flow $11.72M $19.36M $5.476M
YoY Change 113.93% -18.7% -81.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
138009119
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22090000
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Assets
Assets
1677304000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
16277000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
83079000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1723000
CY2022Q3 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
20658000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49913000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
735372000
CY2022Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
51376000
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
37459000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
45494000
CY2022Q3 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
33528000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
172303000
CY2022Q3 us-gaap Goodwill
Goodwill
539016000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22007000
CY2021Q4 us-gaap Assets
Assets
1690657000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15490000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65907000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
301557000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
20750000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
403704000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
47344000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
41573000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4723000
CY2021Q4 us-gaap Liabilities
Liabilities
501368000
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
45790000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
39935000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3352000
CY2022Q3 us-gaap Liabilities
Liabilities
553003000
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
137968304
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
14000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2004995000
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2749000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-877959000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1124301000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1677304000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186429000
us-gaap Net Income Loss
NetIncomeLoss
-215747000
us-gaap Net Income Loss
NetIncomeLoss
-214193000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
589212000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
383253000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1072098000
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.72
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
38183000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
115881000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
185929000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
3171000
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
40434000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
61148695
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200000
us-gaap Gross Profit
GrossProfit
410304000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
109608000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131990000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
518150000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
37779000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
22693000
CY2022Q3 us-gaap Gross Profit
GrossProfit
148650000
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
329072000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
306806000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53447000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
195569000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39362000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
35051000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
123181000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
220463000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
158854000
us-gaap Operating Expenses
OperatingExpenses
625556000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-71813000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-49557000
us-gaap Operating Income Loss
OperatingIncomeLoss
-215252000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40666000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36837000
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001611052
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.59
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.71
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
137180639
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
131438987
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
135888952
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79145139
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264622000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
586108000
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
293430000
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
106749000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
113977000
CY2021Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
17030000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
35173000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
752288000
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
27062000
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
39623000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
44052000
CY2021Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
25889000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
201977000
CY2021Q4 us-gaap Goodwill
Goodwill
540922000
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30475000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
458903000
CY2022Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
5023000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4024000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
137968304
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134046926
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
134046926
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1852071000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-583000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-662212000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1189289000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1690657000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
368718000
us-gaap Cost Of Revenue
CostOfRevenue
107846000
us-gaap Cost Of Revenue
CostOfRevenue
68545000
CY2021Q3 us-gaap Gross Profit
GrossProfit
109297000
us-gaap Gross Profit
GrossProfit
300173000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
70356000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
224226000
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71493000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
176619000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
110805000
us-gaap Operating Expenses
OperatingExpenses
511650000
CY2022Q3 pcor Interest Income
InterestIncome
2143000
CY2021Q3 pcor Interest Income
InterestIncome
51000
CY2022Q3 us-gaap Interest Expense
InterestExpense
504000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-698000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-214016000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
709000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
177000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-50742000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.71
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
137180639
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131438987
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
135888952
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79145139
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1277000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-562000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-786000
CY2022Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-443000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-443000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1720000
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-562000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2166000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-786000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-72925000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51304000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-217913000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-214979000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-272102000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11038000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9710000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-13732000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-265110000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
17658000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
138055000
CY2021Q2 pcor Conversion Of Redeemable Convertible Preferred Stock To Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponInitialPublicOffering
728375000
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
657618000
CY2021Q2 pcor Issuance Of Common Stock Net Of Common Stock Withheld For Tax Liability Upon Settlement Of Restricted Stock Units
IssuanceOfCommonStockNetOfCommonStockWithheldForTaxLiabilityUponSettlementOfRestrictedStockUnits
-15000
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-200000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-149719000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1126662000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5782000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
40434000
CY2021Q3 pcor Adjustments To Additional Paid In Capital Offering Costs
AdjustmentsToAdditionalPaidInCapitalOfferingCosts
11000
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-562000
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-50742000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1121585000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1189289000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6795000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39375000
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
345000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-71419000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1164385000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8220000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
35790000
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
11513000
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-791000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-73123000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1145995000
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4232000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
46999000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1720000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-71205000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
1124301000
us-gaap Profit Loss
ProfitLoss
-215747000
us-gaap Profit Loss
ProfitLoss
-214193000
us-gaap Share Based Compensation
ShareBasedCompensation
115881000
us-gaap Share Based Compensation
ShareBasedCompensation
185929000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
46453000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23269000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
650000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1064000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-554000
pcor Noncash Lease Expense
NoncashLeaseExpense
-7559000
pcor Noncash Lease Expense
NoncashLeaseExpense
-5600000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-881000
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-875000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-350000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
93000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6726000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3383000
pcor Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
12589000
pcor Increase Decrease In Deferred Contract Cost Assets
IncreaseDecreaseInDeferredContractCostAssets
7073000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7256000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
7755000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2141000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-128000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
23064000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
28684000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
29849000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
24721000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7110000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3654000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10084000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40305000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13670000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8405000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
24783000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
10175000
pcor Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
3653000
pcor Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
3450000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
293078000
pcor Proceeds To Acquire Originations Of Materials Financing
ProceedsToAcquireOriginationsOfMaterialsFinancing
16750000
pcor Proceeds To Acquire Customer Repayments Of Materials Financing
ProceedsToAcquireCustomerRepaymentsOfMaterialsFinancing
11997000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
19990000
pcor Settlement Of Post Close Working Capital Adjustments From Business Combinations
SettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinations
1291000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-338646000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42020000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
665129000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19345000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35313000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
270000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3846000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
11513000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
475000
pcor Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
1330000
pcor Repayments Of Long Term Finance Lease Obligations Net Of Proceeds From Lease Incentives
RepaymentsOfLongTermFinanceLeaseObligationsNetOfProceedsFromLeaseIncentives
1175000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29258000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
694946000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-319472000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
693231000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2014000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1040000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
267726000
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
264622000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
242000
CY2022Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3104000
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3104000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
267726000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1075444000
us-gaap Interest Paid Net
InterestPaidNet
77000
us-gaap Interest Paid Net
InterestPaidNet
147000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
746000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
309000
pcor Stock Based Compensation Capitalized For Cloud Computing Arrangement Costs
StockBasedCompensationCapitalizedForCloudComputingArrangementCosts
242000
pcor Stock Based Compensation Capitalized For Cloud Computing Arrangement Costs
StockBasedCompensationCapitalizedForCloudComputingArrangementCosts
231000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
1381000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1420000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1998000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1182000
pcor Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
2192000
pcor Increase Decrease In Accruals For Capitalized Software Development Costs
IncreaseDecreaseInAccrualsForCapitalizedSoftwareDevelopmentCosts
1008000
pcor Net Change In Deferred Offering Costs Accrued But Not Paid
NetChangeInDeferredOfferingCostsAccruedButNotPaid
310000
pcor Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockUponInitialPublicOffering
728375000
pcor Indemnity Holdback Consideration Associated With Business Combination
IndemnityHoldbackConsiderationAssociatedWithBusinessCombination
4050000
pcor Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
6201000
pcor Stock Based Compensation Capitalized For Software Development
StockBasedCompensationCapitalizedForSoftwareDevelopment
2940000
pcor Conversion Of Available For Sale Debt Securities Into Equity Securities
ConversionOfAvailableForSaleDebtSecuritiesIntoEquitySecurities
3680000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11495000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
150000
pcor Noncash Net Change Due To Operating Lease Remeasurements
NoncashNetChangeDueToOperatingLeaseRemeasurements
-1660000
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
152900000
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
111400000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
271900000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
197400000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;margin-left:4.34%;text-indent:0%;;color:#231F20;font-size:10pt;font-weight:bold;font-style:italic;font-family:Arial;text-transform:none;font-variant: normal;">Use<span style="letter-spacing:-0.05pt;"> </span>of estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.34%;color:#231F20;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The<span style="letter-spacing:-0.05pt;"> </span>preparation<span style="letter-spacing:-0.05pt;"> </span>of condensed<span style="letter-spacing:-0.05pt;"> </span>consolidated<span style="letter-spacing:-0.1pt;"> </span>financial<span style="letter-spacing:-0.1pt;"> </span>statements<span style="letter-spacing:0.05pt;"> </span>in<span style="letter-spacing:-0.05pt;"> </span>conformity<span style="letter-spacing:0.05pt;"> </span>with<span style="letter-spacing:-0.05pt;"> </span>U.S. GAAP requires management to make estimates and<span style="letter-spacing:-0.05pt;"> </span>assumptions<span style="letter-spacing:-0.05pt;"> </span>that affect<span style="letter-spacing:0.05pt;"> </span>the reported amounts of assets and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>disclosure<span style="letter-spacing:-0.05pt;"> </span>of contingent<span style="letter-spacing:-0.05pt;"> </span>assets and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>at the date of the condensed<span style="letter-spacing:-0.05pt;"> </span>consolidated<span style="letter-spacing:-0.1pt;"> </span>financial<span style="letter-spacing:-0.1pt;"> </span>statements<span style="letter-spacing:0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>the reported amounts of revenue<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>expenses during<span style="letter-spacing:-0.05pt;"> </span>the reporting period. Management periodically<span style="letter-spacing:-0.1pt;"> </span>evaluates<span style="letter-spacing:-0.05pt;"> </span>its estimates and<span style="letter-spacing:-0.05pt;"> </span>assumptions<span style="letter-spacing:-0.05pt;"> </span>for continued<span style="letter-spacing:-0.05pt;"> </span>reasonableness,<span style="letter-spacing:-0.05pt;"> </span>primarily with<span style="letter-spacing:-0.05pt;"> </span>respect to revenue<span style="letter-spacing:-0.05pt;"> </span>recognition,<span style="letter-spacing:-0.05pt;"> </span>the period<span style="letter-spacing:-0.05pt;"> </span>of benefit of contract<span style="letter-spacing:0.05pt;"> </span>cost assets, the fair value<span style="letter-spacing:-0.05pt;"> </span>of assets acquired<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>liabilities<span style="letter-spacing:-0.15pt;"> </span>assumed in<span style="letter-spacing:-0.05pt;"> </span>a business combination,<span style="letter-spacing:-0.05pt;"> </span>stock-based compensation<span style="letter-spacing:-0.05pt;"> </span>expense, including<span style="letter-spacing:-0.05pt;"> </span>the fair value<span style="letter-spacing:-0.05pt;"> </span>of the Company’s<span style="letter-spacing:-0.05pt;"> </span>common stock prior to the effective date of the Company’s initial public offering (“IPO”)<span style="letter-spacing:0.05pt;">, </span>the recoverability<span style="letter-spacing:-0.05pt;"> </span>of goodwill<span style="letter-spacing:-0.1pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>long-lived<span style="letter-spacing:-0.1pt;"> </span>assets, useful<span style="letter-spacing:-0.05pt;"> </span>lives<span style="letter-spacing:-0.05pt;"> </span>of long-lived<span style="letter-spacing:-0.1pt;"> </span>assets, capitalization<span style="letter-spacing:-0.1pt;"> </span>of software development<span style="letter-spacing:-0.05pt;"> </span>costs<span style="letter-spacing:-0.1pt;">,</span><span style="letter-spacing:-0.05pt;"> </span>income<span style="letter-spacing:-0.05pt;"> </span>taxes, including<span style="letter-spacing:-0.1pt;"> </span>related reserves and<span style="letter-spacing:-0.05pt;"> </span>allowances, and self-insurance reserve estimates. Appropriate<span style="letter-spacing:-0.05pt;"> </span>adjustments, if any, to the estimates used<span style="letter-spacing:-0.05pt;"> </span>are made prospectively<span style="letter-spacing:-0.05pt;"> </span>based<span style="letter-spacing:-0.05pt;"> </span>upon<span style="letter-spacing:-0.05pt;"> </span>such periodic<span style="letter-spacing:-0.05pt;"> </span>evaluation.<span style="letter-spacing:-0.05pt;"> </span>Management bases<span style="letter-spacing:-0.05pt;"> </span>its estimates on historical<span style="letter-spacing:-0.05pt;"> </span>experience<span style="letter-spacing:-0.05pt;"> </span>and<span style="letter-spacing:-0.05pt;"> </span>on various<span style="color:#000000;"> </span>other assumptions<span style="letter-spacing:-0.05pt;"> </span>that management believes<span style="letter-spacing:-0.1pt;"> </span>to be reasonable.<span style="letter-spacing:-0.05pt;"> </span>Actual<span style="letter-spacing:-0.05pt;"> </span>results could<span style="letter-spacing:-0.05pt;"> </span>differ from our estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.34%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In light of the currently unknown duration and severity of the COVID-19 pandemic, we face a greater degree of uncertainty than normal in making the judgments and estimates needed to apply our significant accounting policies. As of the date these condensed consolidated financial statements were issued, the impacts of the COVID-19 pandemic did not have a significant impact on our estimates or judgments. Judgments and assumptions may change, as new events occur and additional information is obtained, as well as other factors related to the COVID-19 pandemic and economic recovery that could result in a meaningful impact on our condensed consolidated financial statements in future reporting periods.</p>
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
714900000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.70
CY2022Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
1700000
CY2022Q3 us-gaap Receivables From Customers
ReceivablesFromCustomers
13600000
CY2021Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
4400000
pcor Cash Equivalents And Marketable Securities Policy Textblock
CashEquivalentsAndMarketableSecuritiesPolicyTextblock
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.34%;font-weight:bold;font-style:italic;color:#231F20;font-size:10pt;font-family:Arial;text-transform:none;font-variant: normal;">Cash equivalents and marketable securities</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.34%;color:#231F20;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company classifies all investments that are readily convertible to known amounts of cash and have maturities of three months or less from the date of purchase as cash equivalents, which are carried at fair value. Investments with stated maturities of greater than three months are classified as marketable securities, which consist of U.S. treasury securities, commercial paper, corporate notes and obligations, and time deposits. The Company determines the appropriate classification of each investment at the time of purchase and reevaluates such classification at each balance sheet date. The Company classifies each marketable debt security as either short-term or long-term at each balance sheet date based on the underlying investment’s contractual maturity date. Short-term investments are investments with an original maturity date of less than one year when purchased. All marketable securities held as of September 30, 2022 are classified and accounted for as short-term available-for-sale debt securities, which are carried at fair value. Investments in marketable securities consist of investment-grade securities and the Company’s investment policy limits the amount of credit exposure to any individual issuer for certain securities.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.34%;color:#231F20;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company periodically assesses its portfolio of marketable securities for impairment. The Company evaluates each investment in an unrealized loss position to determine if any portion of the unrealized loss is related to credit losses. In determining whether a credit loss may exist, the Company considers the extent of the unrealized loss position, any adverse conditions specifically related to the security or the issuer's operating environment, the pay structure of the security, the issuer's payment history, and any changes in the issuer's credit rating. Unrealized losses on marketable securities due to expected credit losses are recognized in other expense, net in the condensed consolidated statement of comprehensive income, and any excess unrealized gains and losses, net of tax, that are not due to expected credit losses are included in accumulated other comprehensive loss, a component of stockholders’ equity. During the nine months ended September 30, 2022, there were no credit losses recorded on marketable securities. Interest recorded on marketable securities is recorded in interest income on the condensed consolidated statement of operations and comprehensive loss.</p>
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
0
CY2022Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
294003000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2022Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
578000
CY2022Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
293430000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0
CY2021Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2021Q4 us-gaap Investments
Investments
7332000
pcor Interest Accrued On Available For Sale Debt Securities
InterestAccruedOnAvailableForSaleDebtSecurities
103000
pcor Payments To Acquire Strategic Investments
PaymentsToAcquireStrategicInvestments
3653000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
166000
CY2022Q3 us-gaap Investments
Investments
11254000
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
312758000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
518357000
CY2022Q3 pcor Operating Lease Right Of Use Assets Operating Lease Liabilities
OperatingLeaseRightOfUseAssetsOperatingLeaseLiabilities
11500000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
223376000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
51073000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
172303000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
224123000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22146000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
201977000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
21.96
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5945635
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5514332
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
11.98
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3400000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y7M6D
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9610000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2397000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28927000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6377000
CY2022Q3 us-gaap Goodwill
Goodwill
539000000.0
pcor Goodwill Decreased By Due To Settlement Of Post Close Working Capital Adjustments From Business Combinations And Effect Of Foreign Currency Translation
GoodwillDecreasedByDueToSettlementOfPostCloseWorkingCapitalAdjustmentsFromBusinessCombinationsAndEffectOfForeignCurrencyTranslation
1900000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q3 pcor Accrued Commissions And Bonuses Current
AccruedCommissionsAndBonusesCurrent
34002000
CY2021Q4 pcor Accrued Commissions And Bonuses Current
AccruedCommissionsAndBonusesCurrent
29676000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
35763000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
25997000
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
13314000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10234000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
83079000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
65907000
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
100000000.0
us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2022-05-07
pcor Line Of Credit Facility Termination Date
LineOfCreditFacilityTerminationDate
2022-04-29
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
6500000
CY2022Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
6500000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7642690
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.98
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1498783
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
198272
pcor Employee Stock Purchase Plan Number Of End Participation Period Description
EmployeeStockPurchasePlanNumberOfEndParticipationPeriodDescription
Participants may end their participation at any time prior to the last 15 days of a purchase period
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
44777000
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2382000
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2251000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
6443000
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
47159000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
122324000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
189100000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15750939
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15251612
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15368414
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186429000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
131990000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
518150000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
368718000

Files In Submission

Name View Source Status
0001564590-22-036765-index-headers.html Edgar Link pending
0001564590-22-036765-index.html Edgar Link pending
0001564590-22-036765.txt Edgar Link pending
0001564590-22-036765-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g2qlbi00vvip000001.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pcor-20220930_cal.xml Edgar Link unprocessable
pcor-20220930_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
pcor-10q_20220930.htm Edgar Link pending
pcor-20220930.xsd Edgar Link pending
pcor-ex101_53.htm Edgar Link pending
pcor-ex311_8.htm Edgar Link pending
pcor-ex312_6.htm Edgar Link pending
pcor-ex321_10.htm Edgar Link pending
pcor-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
pcor-20220930_def.xml Edgar Link unprocessable
pcor-20220930_lab.xml Edgar Link unprocessable
pcor-10q_20220930_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending